![](/img/cover-not-exists.png)
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
Spagnuolo, Vincenzo, Galli, Laura, Poli, Andrea, Bigoloni, Alba, Fumagalli, Luca, Gianotti, Nicola, Nozza, Silvia, Ferrari, Davide, Locatelli, Massimo, Lazzarin, Adriano, Castagna, AntonellaVolume:
Volume 13
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S192124
Date:
January, 2019
File:
PDF, 193 KB
2019